Slichenmyer William 4
4 · AVEO PHARMACEUTICALS INC · Filed Jun 21, 2012
Insider Transaction Report
Form 4
Slichenmyer William
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-06-19$9.64/sh+1,000$9,640→ 24,693 total - Sale
Common Stock
2012-06-19$12.00/sh−1,000$12,000→ 23,693 total - Exercise/Conversion
Stock Option (right to buy)
2012-06-19−1,000→ 111,500 totalExercise: $9.64Exp: 2019-10-08→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
- [F2]The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013.